BK2014 Medical Instruments & Supplies
- 1122.642
- -0.458-0.04%
MicroStrategy Was The Best Among These 10 Large-Cap Stocks Scoring Big Last Week (May 12-May 19, 2024): Are They In Your Portfolio?
These large-cap stocks were the best performers in the last week. Are they in your portfolio?MicroStrategy Incorporated (NASDAQ:MSTR) shares increased 30.10% following a rise in the price of Bitcoin.M
Earnings Call Summary | Akoya Biosciences(AKYA.US) Q1 2024 Earnings Conference
The following is a summary of the Akoya Biosciences, Inc. (AKYA) Q1 2024 Earnings Call Transcript:Financial Performance:Akoya Biosciences reports Q1 2024 total revenue of $18.4 million, highlighting a
Fresenius SE's Future With Dialysis Company Unclear, Investors Seek Answers
Investors demanded more clarity from German healthcare group Fresenius SE regarding its intentions to relinquish strategic control over dialysis group Fresenius Medical Care AG (NYSE:FMS). The investo
$100 Invested In This Stock 10 Years Ago Would Be Worth $400 Today
ResMed (NYSE:RMD) has outperformed the market over the past 10 years by 4.86% on an annualized basis producing an average annual return of 15.65%. Currently, ResMed has a market capitalization of $32.
Reneo Pharmaceuticals And 2 Other Stocks Under $2 Insiders Are Buying
The Dow Jones index closed lower by around 0.1% on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders inter
Earnings Call Summary | Milestone Scientific(MLSS.US) Q1 2024 Earnings Conference
The following is a summary of the Milestone Scientific Inc. (MLSS) Q1 2024 Earnings Call Transcript:Financial Performance:Milestone Scientific recorded Q1 2024 revenue of $2.2 million, seeing a slight
Bionano Genomics Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/16/2024 82.65% BTIG $3 → $2 Maintains Buy 03/07/2024 447.95% Scotiabank $7 → $6 Maintains Sector Outper
Earnings Call Summary | Precision Optics(POCI.US) Q3 2024 Earnings Conference
The following is a summary of the Precision Optics Corporation, Inc. (POCI) Q3 2024 Earnings Call Transcript:Financial Performance:Precision Optics reported Q3 revenue of $5.24 million, a significant
Earnings Call Summary | Predictive Oncology(POAI.US) Q1 2024 Earnings Conference
The following is a summary of the Predictive Oncology Inc. (POAI) Q1 2024 Earnings Call Transcript:Financial Performance:Predictive Oncology concluded Q1 2024 with $5.2 million cash and $4.0 million i
Avinger Q1 2024 GAAP EPS $(2.49) Misses $(1.35) Estimate, Sales $1.859M Miss $2.360M Estimate
Avinger (NASDAQ:AVGR) reported quarterly losses of $(2.49) per share which missed the analyst consensus estimate of $(1.35) by 84.44 percent. This is a 76.73 percent increase over losses of $(10.70) p
Contact Lens Maker Alcon's Has New Growth Avenues, Analyst Upgrades Stock
Oppenheimer has upgraded Alcon Inc (NYSE:ALC) following firm first-quarter earnings and several new drivers coming into view.The analyst sees a new opportunity in glaucoma with the announced acquisiti
Why Bolt Biotherapeutics Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of Bolt Biotherapeutics, Inc. (NASDAQ:BOLT) fell sharply during Wednesday's session after the company reported first-quarter financial results.Bolt Biotherapeutics posted a GAAP loss of 28 cent
What's Going On With NVIDIA Stock Today?
NVIDIA Corporation (NASDAQ:NVDA) shares are trading higher on Wednesday.In a blog post, the company said that a collaboration between NVIDIA and academic researchers is prepping robots for surgery.ORB
$100 Invested In Intuitive Surgical 10 Years Ago Would Be Worth This Much Today
Intuitive Surgical (NASDAQ:ISRG) has outperformed the market over the past 10 years by 14.72% on an annualized basis producing an average annual return of 25.62%. Currently, Intuitive Surgical has a m
Most Shorted S&P 500 Stocks as a Percentage of Float
Short Interest in S&P 500 Healthcare Sector Dips in April, Biotechnology Companies Most Shorted
OPEN, BCRX and AWIN Among Pre-market Gainers
Sanara MedTech Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/15/2024 40.04% Cantor Fitzgerald → $44 Reiterates Overweight → Overweight 03/27/2024 40.04% Cantor Fitz
Alcon Analysts Increase Their Forecasts Following Q1 Results
Alcon Inc. (NYSE:ALC) posted mixed first-quarter financial results, after the closing bell on Monday.Alcon posted adjusted earnings of 78 cents per share, beating market estimates of 73 cents per shar
Nephros Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/15/2024 138.1% Benchmark → $5 Reiterates Speculative Buy → Speculative Buy 03/08/2024 138.1% Benchmark